Anna Hemnes, MD

Anna Hemnes, MD

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Bayer Healthcare Pharmaceuticals(SIGNIFICANT), united therapeutics(SIGNIFICANT), GossamerBio(MODEST), Janssen Pharmaceuticals, Inc(SIGNIFICANT) EQUITY INTERESTS/STOCK OPTIONS: Tenax Therapeutics(SIGNIFICANT)

View Full Disclosure